Dr. Lode Jan Swinnen, MD

Dr. Swinnen practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Swinnen's NPI, 1417988148, was assigned on July 5, 2006. Dr. Swinnen holds Maryland license D59113.

Dr. Swinnen's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Swinnen's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Swinnen is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Swinnen to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Swinnen practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Swinnen's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Swinnen is licensed in Maryland.

CMS data shows 656 Medicare services from Dr. Swinnen across 7 procedure codes in 2024, for 229 Medicare patients. Medicare paid $57,095 for them.

CMS counts 229 Medicare patients who saw Dr. Swinnen in 2024. The largest group is 65 to 74, with 114 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Swinnen's median patient age at 72, with 40% women.

In 2024, Dr. Swinnen wrote 46 Medicare Part D claims for 18 patients. 100% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $70 in total drug cost. In 2021, CMS named 15 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Swinnen for performance year 2024, reported as part of a group. CMS lists Dr. Swinnen as offering telehealth.

Dmand AI links 57 papers to Dr. Swinnen, published from 2011 to 2025. 2017 was the busiest year, with 6. The most frequent topics are Cyclophosphamide, Graft vs Host Disease and Hematopoietic Stem Cell Transplantation. Dr. Swinnen has published most often in J Natl Compr Canc Netw. Dr. Swinnen's most frequent co-authors are Richard Ambinder, MD, Ephraim Joseph Fuchs, MD and Carol Ann Huff, MD.

CMS Open Payments shows 82 general payments to Dr. Swinnen from 8 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 79% of the total. Pharmacyclics LLC, An AbbVie Company paid the most, $12,867. It also lists 8 research payments totaling $1,225 from 2016 to 2024, naming 1 clinical trial.